Beverley practises in all areas of intellectual property litigation, with a focus on complex patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations.
She also advises clients on patent portfolio management, including how to navigate IP Regulatory issues such as listing patents on the Patent Register, and reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection, and the Register of Innovative Drugs as it relates to data protection.
In addition, Beverley advises on patent portfolio management, patentability, validity and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada.
Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients.
Beverley consulted on the implementation and application of the intellectual property provisions of Canada’s trade agreements, including the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and the United States-Mexico-Canada Agreement (USMCA).
Beverley has advocated before the Federal Courts and Federal Court of Appeal, as well as the Patented Medicine Prices Review Board.
Beverley is National Leader of BLG’s Intellectual Property Litigation Group and serves on the firm’s thought leadership committee. She also mentors several of the firm’s students and associates.